adenine has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Using an in vivo model system, we report a simple and sensitive liquid chromatography-tandem mass spectrometry assay to quantify the bioavailability of a recently developed novel cyclin-dependent kinase inhibitor VMY-1-103, a purvalanol B-based analog whose biological activity is enhanced via dansylation." | 1.38 | Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. ( Albanese, C; Das, S; Fricke, ST; Karam, S; Lee, YC; Lisanti, MP; Moasser, B; Ozcan, A; Petricoin, E; Pishvaian, M; Ringer, L; Rodriguez, OC; Rood, B; Salinas, P; Schlegel, R; Sirajuddin, P; Sivakumar, A; Üren, A; Wang, SS; Wang, Y; Yenugonda, V, 2012) |
| "Medulloblastoma is the most prevalent of childhood brain malignancies, constituting 25% of childhood brain tumors." | 1.37 | VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. ( Albanese, C; Brown, ML; Ghosh, A; Glazer, RI; Heckler, M; Lee, Y; MacDonald, TJ; Ringer, L; Rodriguez, O; Schlegel, R; Sirajuddin, P; Suprynowicz, F; Toretsky, JA; Uren, A; Yenugonda, VM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamison, S | 1 |
| Lin, Y | 1 |
| Lin, W | 1 |
| Morfouace, M | 1 |
| Cheepala, S | 1 |
| Jackson, S | 1 |
| Fukuda, Y | 1 |
| Patel, YT | 1 |
| Fatima, S | 1 |
| Kawauchi, D | 1 |
| Shelat, AA | 1 |
| Stewart, CF | 1 |
| Sorrentino, BP | 1 |
| Schuetz, JD | 1 |
| Roussel, MF | 1 |
| Waye, S | 1 |
| Naeem, A | 1 |
| Choudhry, MU | 1 |
| Parasido, E | 1 |
| Tricoli, L | 1 |
| Sivakumar, A | 2 |
| Mikhaiel, JP | 1 |
| Yenugonda, V | 2 |
| Rodriguez, OC | 2 |
| Karam, SD | 1 |
| Rood, BR | 1 |
| Avantaggiati, ML | 1 |
| Albanese, C | 3 |
| Ringer, L | 2 |
| Sirajuddin, P | 2 |
| Heckler, M | 1 |
| Ghosh, A | 1 |
| Suprynowicz, F | 1 |
| Yenugonda, VM | 1 |
| Brown, ML | 1 |
| Toretsky, JA | 1 |
| Uren, A | 2 |
| Lee, Y | 1 |
| MacDonald, TJ | 1 |
| Rodriguez, O | 1 |
| Glazer, RI | 1 |
| Schlegel, R | 2 |
| Das, S | 1 |
| Lee, YC | 1 |
| Fricke, ST | 1 |
| Rood, B | 1 |
| Ozcan, A | 1 |
| Wang, SS | 1 |
| Karam, S | 1 |
| Salinas, P | 1 |
| Petricoin, E | 1 |
| Pishvaian, M | 1 |
| Lisanti, MP | 1 |
| Wang, Y | 1 |
| Moasser, B | 1 |
5 other studies available for adenine and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A.
Topics: Adenine; Cell Line, Tumor; Cell Movement; Cerebellar Neoplasms; eIF-2 Kinase; Endoplasmic Reticulum; | 2015 |
ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, M | 2015 |
The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells.
Topics: Adenine; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Dansyl Compounds; Drug Evaluation, Pre | 2015 |
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.
Topics: Adenine; Antineoplastic Agents; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Centrosome; Cereb | 2011 |
Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.
Topics: Adenine; Animals; Antineoplastic Agents; Biological Availability; Cell Cycle; Cerebellar Neoplasms; | 2012 |